1. Home
  2. PEW vs CLNN Comparison

PEW vs CLNN Comparison

Compare PEW & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEW
  • CLNN
  • Stock Information
  • Founded
  • PEW 2007
  • CLNN 2012
  • Country
  • PEW United States
  • CLNN United States
  • Employees
  • PEW N/A
  • CLNN N/A
  • Industry
  • PEW Other Specialty Stores
  • CLNN Biotechnology: Pharmaceutical Preparations
  • Sector
  • PEW Consumer Discretionary
  • CLNN Health Care
  • Exchange
  • PEW Nasdaq
  • CLNN Nasdaq
  • Market Cap
  • PEW 143.2M
  • CLNN 120.6M
  • IPO Year
  • PEW N/A
  • CLNN N/A
  • Fundamental
  • Price
  • PEW $3.64
  • CLNN $8.57
  • Analyst Decision
  • PEW Strong Buy
  • CLNN Strong Buy
  • Analyst Count
  • PEW 1
  • CLNN 6
  • Target Price
  • PEW $8.25
  • CLNN $32.67
  • AVG Volume (30 Days)
  • PEW 484.3K
  • CLNN 133.3K
  • Earning Date
  • PEW 11-13-2025
  • CLNN 11-13-2025
  • Dividend Yield
  • PEW N/A
  • CLNN N/A
  • EPS Growth
  • PEW N/A
  • CLNN N/A
  • EPS
  • PEW N/A
  • CLNN N/A
  • Revenue
  • PEW $92,782,000.00
  • CLNN $214,000.00
  • Revenue This Year
  • PEW N/A
  • CLNN N/A
  • Revenue Next Year
  • PEW $6.69
  • CLNN $1,363.77
  • P/E Ratio
  • PEW N/A
  • CLNN N/A
  • Revenue Growth
  • PEW N/A
  • CLNN N/A
  • 52 Week Low
  • PEW $3.51
  • CLNN $2.28
  • 52 Week High
  • PEW $21.40
  • CLNN $13.50
  • Technical
  • Relative Strength Index (RSI)
  • PEW 25.51
  • CLNN 47.46
  • Support Level
  • PEW $3.51
  • CLNN $6.59
  • Resistance Level
  • PEW $4.45
  • CLNN $8.86
  • Average True Range (ATR)
  • PEW 0.23
  • CLNN 1.39
  • MACD
  • PEW -0.07
  • CLNN -0.28
  • Stochastic Oscillator
  • PEW 10.36
  • CLNN 28.80

About PEW GrabAGun Digital Holdings Inc. Common Stock

GrabAGun Digital Holdings Inc is a multi-brand eCommerce retailer of firearms, ammunition, and related accessories.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: